Sunitinib rechallenge with dose escalation in progressive metastatic renal cell carcinoma: A case report and literature review

RATIONALE: We aimed to present a case of sunitinib rechallenge with dosage escalation after disease progression, hopefully, providing an optional approach to the personalized medication management of progressive metastatic renal cell carcinoma (mRCC). PATIENT CONCERNS: The patient was admitted to ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xingming, Shen, Pengfei, Yao, Jin, Chen, Ni, Liu, Jiyan, Zeng, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081141/
https://www.ncbi.nlm.nih.gov/pubmed/30075524
http://dx.doi.org/10.1097/MD.0000000000011565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081141/
https://www.ncbi.nlm.nih.gov/pubmed/30075524
http://dx.doi.org/10.1097/MD.0000000000011565

Ejemplares similares